Figure 1. Western blot analysis of LYPLA3/PLA2G15 using anti-LYPLA3/PLA2G15 antibody (A08649). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human placenta tissue lysates, Lane 2: human SIHA whole cell lysates, Lane 3: human U251 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-LYPLA3/PLA2G15 antigen affinity purified polyclonal antibody (Catalog # A08649) at 0.5 microg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for LYPLA3/PLA2G15 at approximately 42-57 kDa. The expected band size for LYPLA3/PLA2G15 is at 65-70 kDa.
Figure 1. Western blot analysis of LYPLA3/PLA2G15 using anti-LYPLA3/PLA2G15 antibody (A08649). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human placenta tissue lysates, Lane 2: human SIHA whole cell lysates, Lane 3: human U251 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-LYPLA3/PLA2G15 antigen affinity purified polyclonal antibody (Catalog # A08649) at 0.5 microg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for LYPLA3/PLA2G15 at approximately 42-57 kDa. The expected band size for LYPLA3/PLA2G15 is at 65-70 kDa.
Anti-LYPLA3/PLA2G15 Antibody Picoband(r)
A08649
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetPLA2G15
Overview
- SupplierBoster Bio
- Product NameAnti-LYPLA3/PLA2G15 Antibody Picoband(r)
- Delivery Days Customer9
- Application Supplier NoteTested Species: In-house tested species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- Gene ID23659
- Target namePLA2G15
- Target descriptionphospholipase A2 group XV
- Target synonyms1-O-acylceramide synthase; ACS; group XV phospholipase A2; GXVPLA2; LCAT-like lysophospholipase; LLPL; LPLA2; LYPLA3; lysophospholipase 3 (lysosomal phospholipase A2); lysosomal phospholipase A and acyltransferase; lysosomal phospholipase A2; phospholipase A2 group XV
- HostRabbit
- IsotypeIgG
- Protein IDQ8NCC3
- Protein NameGroup XV phospholipase A2
- Scientific DescriptionBoster Bio Anti-LYPLA3/PLA2G15 Antibody Picoband® catalog # A08649. Tested in ELISA, IF, ICC, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203